BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Godel M, Ortone G, Anobile DP, Pasino M, Randazzo G, Riganti C, Kopecka J. Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer. Pharmaceutics 2021;13:762. [PMID: 34065551 DOI: 10.3390/pharmaceutics13050762] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Mameri H, Buhagiar-Labarchède G, Fontaine G, Corcelle C, Barette C, Onclercq-Delic R, Beauvineau C, Mahuteau-Betzer F, Amor-Guéret M. Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levels. Cell Mol Life Sci 2022;79:465. [PMID: 35925417 DOI: 10.1007/s00018-022-04487-9] [Reference Citation Analysis]
2 Kopecka J. Mitochondria-Targeted Drug Delivery. Pharmaceutics 2022;14:178. [PMID: 35057073 DOI: 10.3390/pharmaceutics14010178] [Reference Citation Analysis]
3 Soni VK, Mehta A, Ratre YK, Chandra V, Shukla D, Kumar A, Vishvakarma NK. Counteracting Action of Curcumin on High Glucose-Induced Chemoresistance in Hepatic Carcinoma Cells. Front Oncol 2021;11:738961. [PMID: 34692517 DOI: 10.3389/fonc.2021.738961] [Cited by in F6Publishing: 2] [Reference Citation Analysis]